07:27 EDT Phathom Pharmaceuticals (PHAT) sees 2025 revenue $165M-$175M, consensus $159.4M
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Avidity, Phathom mentioned as potential takeout targets at Needham
- Phathom Pharmaceuticals appoints Anne Marie Cook as CLO, corporate secretary
- Largest borrow rate increases among liquid names
- Phathom Pharmaceuticals Gains FDA Exclusivity for VOQUEZNA
- Phathom Pharmaceuticals announces FDA correction to Orange Book Listing